- $562.11m
- $510.07m
- $1.10bn
- 53
- 85
- 78
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 1,201 | 1,069 | 1,066 | 980 | 1,095 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,184 | 1,238 | 966 | 965 | 1,132 |
Operating Profit | 16.9 | -170 | 100 | 15.3 | -36.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 16.9 | -170 | 96.8 | 12.1 | -39.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14.8 | -131 | 80.6 | 15 | -29.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 14.8 | -113 | 80.6 | 15 | -29.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14.8 | -113 | 80.6 | 15 | -29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.579 | -4.85 | 3.16 | 0.597 | -1.18 |
Dividends per Share |